Matthew Brams bought $9,808 of CING
EVP and Chief Medical Officer at Cingulate Inc.. 1,946 shares at an average of $5.04, traded Feb 6, 2026, filed Feb 10, 2026.
Score components
- +15RoleOfficer
- 0Trade size$10k at market
- +10Relative to holdingsHoldings up 72%
- 0Price contextMid range
- +15Cluster5 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +33.7%, 3m -29.8%, 6m -23.8%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001493152-26-006024, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 6, 2026 | POpen-market purchase Common Stock | +1,946 | $5.04 | $9,808 | 4,656 | Feb 10, 2026 |
| Feb 6, 2026 | POpen-market purchase Warrant to Purchase Common Stockderivative | +1,556 | $0.10 | $156 | 1,556 | Feb 10, 2026 |
Related signals
Other insiders at Cingulate Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 62Notable | Cingulate Inc. | Thomas Jeffrey Hargroves director | $490k 97,276 shares | first purchase | |
| 47Moderate | Cingulate Inc. | Jennifer L. Callahan SVP and CFO | $25k 4,864 shares | +2494% | |
| 56Moderate | Cingulate Inc. | Shane J. Schaffer Chief Executive Officer | $34k 6,809 shares | +202% | |
| 43Moderate | Cingulate Inc. | Peter J. Werth director | $98k 19,455 shares | +20% | |
| 40Moderate | CINGsell Cingulate Inc. | Laurie Myers EVP and COO | $841 202 shares | -100% | |
| 30Weak | CINGbuy Cingulate Inc. | Jennifer L. Callahan SVP and CFO | $1,491 55 shares | +2% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.